The Wonderful World of SGLT2 Inhibitors

Overview

Update on the newest treatments in the treatment of diabetes with SGLT2 medications.

Target Audience

All pharmacists

Learning Objectives

At the conclusion of this activity, the attendee will be able to:

 

​•Discuss the pathophysiology and pharmacology of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors 

    •Review evidence behind the use of SGLT2 in patients with Type 2 Diabetes

    •List  the potential benefits SGLT2 inhibitors in patients with Heart Failure and Renal disease  

 

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
01/21/2021
Course expires: 
02/09/2022
Cost:
$10.00
Rating: 
0

Faculty

PGY2 Emergency Medicine Pharmacy Resident

Long Island University/The Brooklyn Hospital Center

Anthony Gerber, PharmD

PGY-2 Ambulatory Care Pharmacy Resident

Long Island University/The Brooklyn Hospital Center

Email: agerber@tbh.org

Telephone: (718) 250-8657

 

No conflicts of interest exist with this presenter.

Accreditation

UAN  0042-0000-21-007-H01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Register/Take course

Price

Cost:
$10.00
Please login or register to take this course.

Required Hardware/software

You need to be able to see the video and hear  the sound for this CE.